TruthArchive.ai - Related Video Feed

Since May 2020, Remdesivir has been linked to a 30% death rate among patients receiving the drug for 5 to 10 days in hospitals. In New York, 26.9% of Medicare-aged patients who received Remdesivir died. The Cardiovascular Toxicology Journal found in October 2020 that Remdesivir is cardiotoxic and can cause death of heart cells. Despite this, the FDA and NIH continue to approve and recommend Remdesivir as the only drug for hospitalized COVID-19 patients. The World Health Organization published in April of last year that Remdesivir leads to increased acute kidney failure compared to other drugs. Shockingly, the FDA recently authorized the use of Remdesivir for newborns and children up to 18 years old.

I have a chart that shows the CDC and FDA's own numbers on adverse events. Despite social media censorship, these are the true numbers. Over 28 years of reporting, Ivermectin, Hydroxychloroquine, and Dexamethasone are shown to be safe drugs. However, since the COVID pandemic, remdesivir and the COVID vaccines have had adverse events. Our response to COVID has been a failure, with 4% of the world's population but supposedly 16% of the deaths. The VAERS system has recorded 1,600,000 adverse events from the COVID vaccines alone.

At home, it is recommended to treat viral replication by giving remedies like zinc and hydroxychloroquine, ivermectin, which reduce the spread of the disease. However, the protocol followed was different. No treatment was given until hospitalization, where ventilators and Remdesivir were used. It is known that Remdesivir can be harmful, as it caused side effects in Ebola patients. The drug was manipulated and made standard of care, leading to kidney failure, heart failure, and organ collapse in COVID-19 patients. The deaths during the pandemic were often attributed to kidney failure, which was caused by Remdesivir, not the virus itself.

The 2018 FDA guidance recommended using drugs off-label for unmet medical needs. Hydroxychloroquine, Ivermectin, colchicine, doxycycline, Azithromycin, budesonide, prednisone, and enoxaparin were used to treat COVID-19. However, certain drugs like hydroxychloroquine faced strong opposition. Clive Palmer in Australia procured hydroxychloroquine for the entire population, but it was seized and destroyed by authorities. The motive behind targeting these drugs is unclear. If they were proven useful, there would be no need for vaccine mandates. It's questioned why people couldn't use hydroxychloroquine or Ivermectin if they were willing to try and pay for them, even if they didn't work.

Since May 2020, Remdesivir has been linked to a 30% death rate among patients receiving the drug in hospitals for 5 to 10 days. In New York, 26.9% of Medicare-aged patients who received Remdesivir died. The Cardiovascular Toxicology Journal found in October 2020 that Remdesivir causes heart cell death and is cardiotoxic. However, the FDA and NIH continue to approve and recommend Remdesivir as the only drug for hospitalized COVID-19 patients, despite the World Health Organization's report in April of last year that it causes increased acute kidney failure. Shockingly, the FDA recently authorized the use of Remdesivir for newborns and children up to 18 years old.

Since May 2020, remdesivir may result in at least 30% death in hospitalized patients who receive it for five to ten days. CMS data for Medicare patients in New York showed 26.9% of those who received remdesivir died. In October 2020, the cardiovascular toxicology journal found remdesivir causes death of heart cells, is cardiotoxic, and can lead to cardiac arrest. Despite this, in December 2020, the NIH, with Anthony Fauci, updated guidelines listing remdesivir as the only FDA-approved drug for hospitalized Americans, even though the WHO published data in April of last year that it increases acute kidney failure compared to other drugs used to treat COVID-19. As of January 21st of this year, the FDA extended emergency use authorization, making remdesivir the only authorized medication that can be administered intravenously to newborns to 18-year-olds for COVID-19.

There are numerous studies showing the significant benefits of Ivermectin, with a 70 to 85% reduction in hospitalizations and deaths. It has been effective worldwide, including in countries like Nigeria, which has the highest burden of river blindness but the lowest COVID death rate. They use both Ivermectin and hydroxychloroquine. Similarly, states in India like Kerala and Uttar Pradesh had comparable death rates by following a protocol that included Ivermectin and hydroxychloroquine. There are over 400 studies supporting the benefits of hydroxychloroquine and nearly 100 studies showing the devastating benefits of Ivermectin. However, a few government-produced studies financed by Bill Gates and the WHO claim no benefit, but these studies have been criticized.

I hope they use hydroxychloroquine and Z Pak with doctor's approval. It's been around for a long time, so why not try it? I want to avoid ventilators because the outcomes are not good. Hydroxychloroquine could be a game-changer if it works. It's their choice to take it, but I recommend trying it. Avoid Z Pak if you have a heart condition. Let's keep people off ventilators and find a better solution.

Ivermectin is extremely safe, arguably safer than a sugar pill. In a randomized trial, those taking Ivermectin daily would likely experience fewer health issues than those on sugar pills. The narrative labeling Ivermectin as a toxic horse dewormer is misleading; over 3.7 billion doses have been administered to humans. It has significantly impacted global health by nearly eradicating several parasitic diseases. In fact, the risk of death from Tylenol is higher than from Ivermectin. While there are debates about its efficacy, in situations with limited options, using a safe and inexpensive drug like Ivermectin for sick patients seems reasonable.

Over 100 studies have shown that Ivermectin has had significant benefits, reducing hospitalizations and deaths by 70 to 85%. It was effective worldwide, including in Nigeria, where they used it for river blindness and had the lowest COVID death rate. Similarly, states in India like Kerala and Uttar Pradesh used our protocol with Ivermectin and hydroxychloroquine, ending the pandemic overnight. There are around 400 studies supporting the benefits of hydroxychloroquine and nearly 100 studies showing the devastating benefits of Ivermectin. However, a few government-produced studies financed by Bill Gates and the WHO claim no benefit, but these studies have been criticized.

In March, I started researching my protocol and started writing the protocols; there were like contraindications to hydroxychloroquine. There were three pages of medications. The protocol was approved by the FDA within twenty four hours and “move to market... start giving it to patients, proceed.” Twenty four hours later, “the politics” and lobbyists allegedly said, “we can't have a cheap drug… kill the market.” A Bill Gates letter asked, “when do you think you're going to, you're anticipating finishing your protocol?” Twitter destroyed it for being open label, and the effort was described as “a political move to destroy a drug.” The Lancet paper is claimed fake: “There is no way that four or five authors took 17,000 records” and “sixty… 96,000 patients”; “Australia doesn't even have COVID yet” and “Ninety six thousand… fraudulent.” NIH notes “chloroquine and hydroxychloroquine toxicity” with “excellent oral absorption and bioavailability” and retinal toxicity is the concern, but in ICU patients the death overshadows it: “He's dead. It doesn't matter that he's got retinal toxicity.”

In 2020, there was a disinformation campaign against Hydroxychloroquine, a generic drug. The pharmaceutical industry opposes generic drugs as they reduce profits. They conducted trials with toxic doses of Hydroxychloroquine, causing increased deaths. On the other hand, Ivermectin is beneficial when given in higher doses. The spike protein in COVID-19 causes clotting issues and suppresses interferon, a chemical that helps fight infections and cancer. Medicines like Ivermectin and others can boost interferon levels and prevent clotting by binding to receptors. Some patients given high doses of Ivermectin have shown remarkable recovery, as it competes with the spike protein for binding sites and prevents clot formation.

Doctors were aware that hydroxychloroquine was safe until the media suggested otherwise. They claimed it was both safe and effective, but when the narrative shifted to it being unsafe, despite its 70-year history and a government database showing it to be safer than Tylenol, it raised concerns. The assertion of its lack of safety felt like a significant deception.

Treating viral replication at home can be done with zinc and zinc-enhancing remedies like hydroxychloroquine and ivermectin. However, the protocol followed during the pandemic did not include these treatments. Instead, patients were only treated when they reached the hospital, where they were given ventilators and Remdesivir. It is known that Remdesivir can be lethal, as it caused kidney failure, heart failure, and organ collapse in many cases. The deaths during the pandemic were often attributed to kidney failure, which was actually caused by Remdesivir, not the virus itself.

The forest plot shows COVID medicines, with only expensive ones approved in the US. Cheaper options were ignored. Study endpoints were changed when results weren't as expected. Despite positive outcomes in trials, hydroxychloroquine and Ivermectin face negative perceptions in the US. Over 420 trials on hydroxychloroquine and 100 on Ivermectin show significant benefits, but they are still viewed negatively.

Multiple studies, including one by the WHO, show that Remdesivir actually increases the risk of death. It's concerning that the federal government incentivizes hospitals to prescribe this toxic drug by offering a 20% bonus on the entire hospital bill for Medicare patients. Remdesivir costs around $3,000 per course. On the other hand, Ivermectin, as mentioned by Dr. Kory, reduces the risk of death by about 50%. Unfortunately, clinicians still use the wrong drug, Dexamethasone, in the wrong dose and for the wrong duration of time, simply because the NIH recommends it. The NIH and other agencies have disregarded multiple FDA-approved drugs that are both cost-effective and safe.

At home, it is recommended to treat viral replication by giving zinc and other zinc-enhancing remedies like hydroxychloroquine and Ivermectin. However, the protocol followed by hospitals was to provide no treatment until admission, and then use ventilators and Remdesivir, which were known to be harmful. Tony Fauci was aware of the dangers of Remdesivir, as it caused lethal side effects in Ebola patients. Despite this, he manipulated a study to make Remdesivir the standard of care, resulting in kidney failure, heart failure, and organ collapse in COVID-19 patients. The deaths attributed to the virus were actually caused by Remdesivir.

To treat viral infections at home, zinc and its enhancers, like hydroxychloroquine and ivermectin, should be used, as they significantly reduce disease spread. However, the established protocol delayed treatment until hospitalization, where patients received ventilators and remdesivir—both potentially lethal. Remdesivir had previously shown harmful effects in Ebola trials, leading to its discontinuation due to a high rate of severe side effects. Despite this, it became standard care during the pandemic, contributing to kidney failure, heart failure, and organ collapse in patients. Many who died were reported to have kidney failure, which was not caused by the virus but rather by the effects of remdesivir.

A recent study claimed that 17,000 people died from Hydroxychloroquine, but Robert Kennedy Jr. pointed out flaws in the study. The drug was given to COVID patients already in the hospital instead of within the first 10 to 14 days when it is effective. The dosage administered was also much higher than recommended. While these mistakes may have contributed to deaths, it is important to consider how many lives could have been saved if the drug was used correctly. Hydroxychloroquine has been widely used for malaria and sometimes drugs are discovered to have additional benefits. The politicization of these drugs is unfortunate, especially considering their affordability.

Over 100 studies have shown that Ivermectin has had significant benefits, reducing hospitalizations and deaths by 70 to 85%. It has been widely used around the world, including in Nigeria, where it helped lower the COVID death rate. Kerala and Uttar Pradesh states in India also used Ivermectin and hydroxychloroquine, effectively ending the pandemic. Numerous studies, including 400 on hydroxychloroquine and nearly 100 on Ivermectin, demonstrate their benefits. However, a few government-funded studies, including those by the WHO and financed by Bill Gates, claim no benefits but have been criticized for their methodology. For more information, you can visit the websites of Dr. Meryl Masse or Yale epidemiologist Harvey Riesch.

Hydroxychloroquine was initially praised for its potential in reducing COVID-19 symptoms and hospitalizations. However, it soon faced widespread criticism worldwide. In Australia, billionaire Clive Palmer purchased a large supply of hydroxychloroquine for the entire continent, intending to distribute it for free. Unfortunately, the Australian authorities seized and destroyed the medication.

Dix-sept-mille décès pourraient être attribués à l'hydroxychloroquine, un médicament utilisé pendant la pandémie de Covid-19. Autorisé à titre compassionnel, il a été retiré en raison de risques cardiaques et de l'absence de bénéfices prouvés. Une étude estime que 200 décès en France pourraient être liés à ce médicament, mais les données sont limitées. La prescription de l'hydroxychloroquine doit donc être faite avec prudence lors de futures épidémies. Translation: Seventeen thousand deaths could be attributed to hydroxychloroquine, a medication used during the Covid-19 pandemic. Authorized on a compassionate basis, it was withdrawn due to cardiac risks and lack of proven benefits. A study estimates that 200 deaths in France could be linked to this drug, but the data is limited. The prescription of hydroxychloroquine should therefore be done with caution during future epidemics.

The forest plot shows COVID medicines, with only expensive ones approved in the US. Cheaper drugs were ignored. Studies manipulated endpoints and faced negative PR. Over 420 trials on hydroxychloroquine and 100 on Ivermectin show significant benefits, but they are dismissed in the US.

A study on Ivermectin's effectiveness in reducing COVID-19 deaths has been peer-reviewed and published. The study analyzed excess deaths in Peru in 2020 and found that states with intensive Ivermectin use had a 74% reduction in excess deaths. When Ivermectin use was restricted, there was a 13-fold increase in deaths. The study concluded that Ivermectin showed strong evidence of effectiveness, considering potential confounding factors. The study was published on August 8th, 2022.

I've stated since May 2020 that remdesivir will result in at least 30% death in those who receive it in the hospital. I had data pulled for Medicare patients in New York, and found that 26.9% of those who received remdesivir died. As of October 2020, the cardiovascular toxicology journal found that remdesivir causes death of heart cells and can lead to cardiac arrest. Yet, in December, the NIH decided to update all guidelines for treatment drugs allowed for COVID-19, and remdesivir was the only FDA-approved drug for hospitalized Americans, despite the WHO publishing that it causes increased acute kidney failure. As of January of this year, the FDA extended an emergency use authorization, making remdesivir the only authorized medication that can be administered to newborns to 18-year-olds.